Your browser doesn't support javascript.
loading
An Initial Experience of Completion Hemispherotomy via Magnetic Resonance-Guided Laser Interstitial Therapy.
Ravindra, Vijay M; Ruggieri, Lucia; Gadgil, Nisha; Addison, Angela P; Patino, Ilana; Gonda, David D; Chu, Jason; Whitehead, Laura; Anderson, Anne; Diaz-Medina, Gloria; Houck, Kimberly; Katyayan, Akshat; Masters, Laura; Nath, Audrey; Quach, Michael; Riviello, James John; Seto, Elaine; Sully, Krystal Elizabeth; Agurs, Latanya; Sen, Sonali; Handoko, Maureen; Coorg, Rohini; Ali, Irfan; Ikeda, Daniel; Weiner, Howard; Curry, Daniel J.
Afiliação
  • Ravindra VM; Division of Pediatric Neurosurgery, Department of Surgery, Texas Children's Hospital, Houston, Texas, USA.
  • Ruggieri L; Department of Neurosurgery, Naval Medical Center San Diego, San Diego, California, USA.
  • Gadgil N; Department of Neurosurgery, University of California San Diego, San Diego, California, USA.
  • Addison AP; Division of Pediatric Neurosurgery, Department of Surgery, Texas Children's Hospital, Houston, Texas, USA.
  • Patino I; Division of Pediatric Neurosurgery, Department of Surgery, Texas Children's Hospital, Houston, Texas, USA.
  • Gonda DD; Department of Neurosurgery, Baylor College of Medicine, Houston, Texas, USA.
  • Chu J; Department of Neurosurgery, Baylor College of Medicine, Houston, Texas, USA.
  • Whitehead L; Division of Pediatric Neurosurgery, Department of Surgery, Texas Children's Hospital, Houston, Texas, USA.
  • Anderson A; Department of Neurosurgery, Baylor College of Medicine, Houston, Texas, USA.
  • Diaz-Medina G; Department of Neurosurgery, University of California San Diego, San Diego, California, USA.
  • Houck K; Department of Neurosurgery, Children's Hospital of Los Angeles/Keck School of Medicine at University of Southern California, Los Angeles, California, USA.
  • Katyayan A; Division of Neurology and Developmental Neuroscience, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.
  • Masters L; Division of Neurology and Developmental Neuroscience, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.
  • Nath A; Division of Neurology and Developmental Neuroscience, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.
  • Quach M; Division of Neurology and Developmental Neuroscience, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.
  • Riviello JJ; Division of Neurology and Developmental Neuroscience, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.
  • Seto E; Division of Neurology and Developmental Neuroscience, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.
  • Sully KE; Division of Neurology and Developmental Neuroscience, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.
  • Agurs L; Division of Neurology and Developmental Neuroscience, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.
  • Sen S; Division of Neurology and Developmental Neuroscience, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.
  • Handoko M; Division of Neurology and Developmental Neuroscience, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.
  • Coorg R; Division of Neurology and Developmental Neuroscience, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.
  • Ali I; Division of Neurology and Developmental Neuroscience, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.
  • Ikeda D; Division of Neurology and Developmental Neuroscience, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.
  • Weiner H; Division of Neurology and Developmental Neuroscience, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.
  • Curry DJ; Division of Neurology and Developmental Neuroscience, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.
Stereotact Funct Neurosurg ; 101(3): 179-187, 2023.
Article em En | MEDLINE | ID: mdl-37062282
ABSTRACT

INTRODUCTION:

In carefully selected patients with medically refractory epilepsy, disconnective hemispherotomy can result in significant seizure freedom; however, incomplete disconnection can result in ongoing seizures and poses a significant challenge. Completion hemispherotomy provides an opportunity to finish the disconnection. We describe the use of magnetic resonance-guided laser interstitial thermal ablation (MRgLITT) for completion hemispherotomy.

METHODS:

Patients treated with completion hemispherotomy using MRgLITT at our institution were identified. Procedural and seizure outcomes were evaluated retrospectively.

RESULTS:

Five patients (3 males) underwent six MRgLITT procedures (one child treated twice) for completion hemispherotomy at a median age of 6 years (range 1.8-12.9). Two children had hemimegalencephaly, two had Rasmussen encephalitis, and one had polymicrogyria. All five children had persistent seizures likely secondary to incomplete disconnection after their functional hemispherotomy. The mean time from open hemispherotomy to MRgLITT was 569.5 ± 272.4 days (median 424, range 342-1,095). One patient underwent stereoelectroencephalography before MRgLITT. The mean number of ablation targets was 2.3 ± 0.47 (median 2, range 2-3). The mean length of the procedure was 373 min ± 68.9 (median 374, range 246-475). Four of the five patients were afforded improvement in their neurocognitive functioning and speech performance after ablation, with mean daily seizure frequency at 1 year of 1.03 ± 1.98 (median 0, range 0-5). Two patients achieved Engel Class I outcomes at 1 year after ablation, one was Engel Class III, and two were Engel Class IV. The mean follow-up time was 646.8 ± 179.5 days (median 634, range 384-918). No MRgLITT-related complications occurred. Delayed retreatment (>1 year) occurred in three patients one child underwent redo ablation and two underwent anatomic hemispherectomy.

CONCLUSION:

We have demonstrated the feasibility of a minimally invasive approach for completion hemispherotomy using MRgLITT. Delayed retreatment was needed in three patients; thus, further study of this technique with comparison to other surgical techniques is warranted.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hemisferectomia / Terapia a Laser / Epilepsia Resistente a Medicamentos Tipo de estudo: Observational_studies Limite: Child / Child, preschool / Humans / Infant / Male Idioma: En Revista: Stereotact Funct Neurosurg Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hemisferectomia / Terapia a Laser / Epilepsia Resistente a Medicamentos Tipo de estudo: Observational_studies Limite: Child / Child, preschool / Humans / Infant / Male Idioma: En Revista: Stereotact Funct Neurosurg Ano de publicação: 2023 Tipo de documento: Article